Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Falsone, SF; Leitinger, G; Karner, A; Kungl, AJ; Kosol, S; Cappai, R; Zangger, K.
The neurotransmitter serotonin interrupts α-synuclein amyloid maturation.
Biochim Biophys Acta. 2011; 1814(5):553-561
Doi: 10.1016/j.bbapap.2011.02.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Falsone Salvatore Fabio
- Co-Autor*innen der Med Uni Graz
-
Leitinger Gerd
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Indolic derivatives can affect fibril growth of amyloid forming proteins. The neurotransmitter serotonin (5-HT) is of particular interest, as it is an endogenous molecule with a possible link to neuropsychiatric symptoms of Parkinson disease. A key pathomolecular mechanism of Parkinson disease is the misfolding and aggregation of the intrinsically unstructured protein α-synuclein. We performed a biophysical study to investigate an influence between these two molecules. In an isolated in vitro system, 5-HT interfered with α-synuclein amyloid fiber maturation, resulting in the formation of partially structured, SDS-resistant intermediate aggregates. The C-terminal region of α-synuclein was essential for this interaction, which was driven mainly by electrostatic forces. 5-HT did not bind directly to monomeric α-synuclein molecules and we propose a model where 5-HT interacts with early intermediates of α-synuclein amyloidogenesis, which disfavors their further conversion into amyloid fibrils.
- Find related publications in this database (using NLM MeSH Indexing)
-
Amyloid - chemistry
-
Circular Dichroism -
-
Electrophoresis, Polyacrylamide Gel -
-
Humans -
-
Magnetic Resonance Spectroscopy -
-
Microscopy, Electron, Transmission -
-
Neurotransmitter Agents - pharmacology
-
Protein Binding - drug effects
-
Serotonin - pharmacology
-
alpha-Synuclein - chemistry
- Find related publications in this database (Keywords)
-
Protein misfolding
-
Amyloid
-
Aggregation
-
Parkinson disease
-
Neurodegeneration
-
Indoleamine